Atlas Trials

Adjunctive Therapy of Exenatide or Sitagliptin to Insulin Glargine in Type 2 Diabetes

Clinical trial NCT00971659 · COMPLETED

Trial details

NCT number
NCT00971659
Sponsor
Profil Institut für Stoffwechselforschung GmbH
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Type 2 Diabetes
Start date
2008-01-01
Primary completion
2008-09-01
Enrollment
48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.